The crosstalk between directly acting antivirals and chronic HCV patients with different stages of renal affection: A multicenter study - 03/12/23

Mohamed El-Kassas ^{a, ⁎} , Amira El Balakosy ^b, Mohamed Elbadry ^a, Ossama Ashraf Ahmed ^c, Christina Alphonse Anwar ^c, Mohammad Abd Algaber ^d, Tari George Michael ^c, Adel El Tahan ^e, Mohamed Alboraie ^f, Gina Meleak ^c, Maraw Tahoon ^g, Ahmed Sherief ^b, Khaled Raafat ^c, Hend Radwan ^h, Basem Eysa ⁱ, Haitham Ezzat Abdelaziz ^c, Yasmeen Ahmed ^b, Mohammed Aboul-Ezz ^j, Abeer Awad ^k

^a Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt 

^b Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt 

^c Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt 

^d Gastroenterology & Hepatology, Police Authority Hospitals, Giza, Egypt 

^e New Cairo Viral Hepatitis Treatment Unit, New Cairo Hospital, Cairo, Egypt 

^f Department of Internal Medicine, Al-Azhar University, Cairo, Egypt 

^g Department Epidemiology and Preventive Medicine, National Liver Institute, Menoufia University, Shebin El Kom, Egypt 

^h Internal Medicine Department, Medicine and Clinical Studies Research Institute, National Research Centre, Cairo, Egypt 

ⁱ Hepatology and Gastroenterology Department, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt 

^j Hepatology and Gastroenterology Department, Theodor Bilharz Research Institute, Cairo, Egypt 

^k Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt 

^⁎Corresponding author at: Endemic Medicine Department, Faculty of Medicine, Helwan University, Ain Helwan, 11795, Cairo, Egypt.Endemic Medicine Department, Faculty of MedicineHelwan UniversityAin HelwanCairo11795Egypt

Le texte complet de cet article est disponible en PDF.